Walleye Capital
BHVN icon

Walleye Capital’s Biohaven BHVN Stock Holding History

Walleye Capital’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$319K Sell
37,700
-9,400
-20% -$103K ﹤0.01% 3021
2025
Q4 		$532K Buy
47,100
+34,800
+283% +$431K ﹤0.01% 2926
2025
Q3 		$185K Sell
12,300
-2,700
-18% -$39.3K ﹤0.01% 3368
2025
Q2 		$212K Buy
15,000
+10,200
+213% +$182K ﹤0.01% 3318
2025
Q1 		$115K Buy
+4,800
New +$169K ﹤0.01% 3558
2024
Q3 		– Sell
-9,200
Closed -$319K – 5299
2024
Q2 		$319K Buy
9,200
+8,300
+922% +$328K ﹤0.01% 3922
2024
Q1 		$49.2K Sell
900
-5,300
-85% -$262K ﹤0.01% 4682
2023
Q4 		$265K Sell
6,200
-8,100
-57% -$252K ﹤0.01% 3471
2023
Q3 		$372K Buy
14,300
+13,200
+1,200% +$274K ﹤0.01% 3049
2023
Q2 		$26.3K Sell
1,100
-17,200
-94% -$296K ﹤0.01% 3757
2023
Q1 		$250K Buy
+18,300
New +$291K ﹤0.01% 2284

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return